WHO ICTRP trial
Comparative Study on the Clinical Efficacy of Acetazolamide and Methazolamide in…
ChiCTR2400089203 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400089203 |
|---|---|
| Public title | Comparative Study on the Clinical Efficacy of Acetazolamide and Methazolamide in Acute Mountain Sickness |
| Scientific title | Comparative Study on the Clinical Efficacy of Methazolamide and Acetazolamide in the Prevention of Acute Mountain Sickness |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | CHINA |
| Conditions | Acute mountain sickness |
| Interventions | Acetazolamide Intervention Group:Take 500 mg of acetazolamide daily (250 mg each time, twice a day) for 1-3 days. On the 4th day, travel to Litang by car. Continue taking acetazolamide for days 4-6.;Methazolamide Intervention Group:Take 200… |
| Registration date | Sep 3, 2024 |
| Target size | Acetazolamide Intervention Group:26;Methazolamide Intervention Group:26 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: